<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03535415</url>
  </required_header>
  <id_info>
    <org_study_id>GenSci GH AQ CT-CKD</org_study_id>
    <nct_id>NCT03535415</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation</brief_title>
  <official_title>A Phase 3 Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GeneScience Pharmaceuticals Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Children's Hospital of Fudan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital of Shanghai</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Children's Hospital, Zhejiang University School Of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's hospital capital institute of pediatrics</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking University First Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fuzhou General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Zhengzhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shengjing Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital of Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tongji medical college huazhong university of science &amp; technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>GeneScience Pharmaceuticals Co., Ltd.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate the efficacy and safety of recombinant human growth hormone
      injection in short stature children due to chronic kidney disease before transplantation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">May 2018</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The change of height standard deviation score of chronological age before and after treatment (ΔHT SDS)</measure>
    <time_frame>52 weeks，104 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Growth velocity</measure>
    <time_frame>12 months, 24 months</time_frame>
    <description>365.25*（height at the time of assessment -height at baseline）/duration of treatment(days)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone maturation ( bone age/ chronological age: BA/CA)</measure>
    <time_frame>12 months, 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IGF-1 (Insulin-like growth factor 1) SDS</measure>
    <time_frame>12 months, 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IGF-1/IGFBP-3 molar ratio</measure>
    <time_frame>12 months, 24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">68</enrollment>
  <condition>Dwarfism</condition>
  <arm_group>
    <arm_group_label>rhGH Injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>rhGH 0.05mg/kg/d by subcutaneous injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-treatment control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Only follow-up without treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Recombinant Human Growth Hormone Injection (rhGH)</intervention_name>
    <description>rhGH 0.05mg/kg/d by subcutaneous injection</description>
    <arm_group_label>rhGH Injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed informed consent of the subjects or the legal guardian.

          -  Subjects and guardian are willing and able to cooperate to complete scheduled
             visits,treatment plans and laboratory tests and other procedures.

          -  Diagnosed as chronic kidney disease.

          -  Glomerular filtration rate (GFR) &lt;75ml/per min/1.73m2.

          -  After the treatment and adjustment of hypertension, anemia, metabolic acidosis,
             malnutrition, renal osteopathy, hypothyroidism, etc..

          -  Chronological age: ≥2years and ≤14years.

          -  Height Standard Deviation Score(HtSDS) ≤-2SD for chronological age.

          -  Bone age: girls≤10 years; boys≤11years.

          -  Pre-pubertal (Tanner Stage I ) patients.

          -  No history of growth hormone treatment.

        Exclusion Criteria:

          -  Subjects with abnormal liver functions.

          -  Subjects positive for anti-HBc, HbsAg or HbeAg in Hepatitis B virus tests.

          -  After adjustment heart function,Cardiac ejection fraction(EF) &lt;50%.

          -  Subjects with highly allergic constitution or allergy to proteins or investigational
             product or its excipient.

          -  Subjects with systemic chronic disease or general infection or mental disease.

          -  Subjects with diabetes or impaired fasting glucose.

          -  Subjects with tumor or potential tumor.

          -  Subjects who are using glucocorticoid or immunosuppressant.

          -  Other causes for growth retardation.

          -  Inability to obtain accurate height measurements.

          -  Subjects who took part in other clinical trials within 3 months.

          -  Concomitant administration of other treatment that may have an effect on growth within
             3 months.

          -  Other conditions which are unsuitable for this study in the opinion of the
             investigator.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hong Xu, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital of Fudan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiaohua Feng</last_name>
    <phone>13610794989</phone>
    <email>fengxiaohua@gensci-china.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fuzhou general hospital of Nanjing military command</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zihua Yu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The first affiliated hospital of zhengzhou university</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianjiang Zhang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tongji medical college huazhong university of science &amp; technology</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianhua Zhou</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shengjing hospital of chian medical university</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yubin Wu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yufeng Li</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Children's Hospital ,Zhejiang University School of Medicine</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianhua Mao</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beijing Children's Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ying Shen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's hospital capital institute of pediatrics</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chaoying Chen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peking university first hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huijie Xiao</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's hospital of Chongqing medical university</name>
      <address>
        <city>Chongqing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mo Wang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Fudan University</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hong Xu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Shanghai</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wenyan Huang</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2018</study_first_submitted>
  <study_first_submitted_qc>May 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 24, 2018</study_first_posted>
  <last_update_submitted>May 22, 2018</last_update_submitted>
  <last_update_submitted_qc>May 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Dwarfism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

